Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe most common side effects of semaglutide tablets are gastrointestinal: nausea, diarrhoea, constipation, and stomach discomfort are reported by a significant proportion of people, particularly in the early weeks of treatment. In the OASIS 4 phase-3 trial, around 74% of participants taking oral semaglutide experienced a GI side effect at some point, compared with 42% on placebo — though most were mild to moderate and settled over time. These are prescription-only medicines assessed individually by a prescriber before treatment begins, because how your body responds depends on factors that vary from person to person.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Starting a new medicine involves a decision: is what I might feel worth what I'm hoping to gain? With semaglutide tablets, the honest answer is that digestive discomfort is genuinely common, especially in the first month. Nausea tops the list. Vomiting, loose stools, constipation, burping and acid reflux also appear with meaningful frequency. In the OASIS 4 trial data, these effects were most concentrated early in treatment and after each dose increase, that 1.5mg to 4mg step, or 4mg to 9mg, often brings a brief recurrence of symptoms that had already settled.
The NHS semaglutide medicines page lists fatigue, headache and dizziness alongside the GI cluster. Less often, people notice injection-site-like reactions aren't relevant here (this is a tablet), but upper abdominal discomfort (a distinct sensation from ordinary nausea) is worth distinguishing, because in rare cases it signals something that needs prompt attention.
A practical thing that takes under a minute: before you take your morning tablet, note whether you've waited at least 30 minutes after waking and haven't had anything other than a small sip of plain water. The absorption-enhancer in the tablet only works in a very specific stomach environment. Taking it with coffee, or eating immediately after, can reduce how much semaglutide your body actually absorbs, and may exacerbate nausea unnecessarily. It's worth building a habit of checking that window.
For a fuller look at how individual dose steps relate to tolerability, the oral semaglutide side effects page goes into more detail on each phase of titration.
Most people's experience of semaglutide tablets involves manageable discomfort, not crisis. But some side effects, though uncommon, are serious enough to warrant a clear description of what to watch for.
Acute pancreatitis is the one to know. In January 2026, following a review across the GLP-1 drug class, the MHRA published a Drug Safety Update confirming pancreatitis as a known, infrequent but potentially serious risk. The symptom pattern is specific: severe, persistent stomach pain that doesn't come and go (it stays) and often radiates into the back. It may or may not accompany vomiting. If this describes what you're feeling, stop the tablet and seek urgent medical help rather than waiting to see if it improves.
Gallbladder problems are another category to understand. Rapid weight loss of any cause can increase gallstone risk, and GLP-1 medicines add a modest independent contribution. Gallbladder pain tends to concentrate in the upper right side of the abdomen, sometimes spreading to the shoulder, and can follow a fatty meal. It's often sharp rather than the dull nausea most people associate with this medicine.
Severe dehydration from prolonged vomiting or diarrhoea can stress the kidneys. If you genuinely can't keep fluids down for more than 24 hours, that's a reason to contact your GP or call 111, not to push through.
Allergic reactions are rare but include swelling of the face, throat or tongue, or difficulty breathing. These require emergency services immediately.
Our clinical team reviews your full medical history before any prescription is issued, precisely so that risks like these can be assessed against your individual circumstances.
Because the tablet route is new) the MHRA approved it as the UK's first oral GLP-1 for weight management in June 2026, there's a reasonable question about whether the side-effect profile differs from the weekly injection. The short answer is: broadly similar, but with some nuances that matter.
The overall GI rate in the OASIS 4 trial (74% experiencing at least one GI event) was somewhat higher than typically reported in injection trials, likely because oral bioavailability is sensitive to exactly how and when the tablet is taken. Someone who occasionally misses the 30-minute pre-meal window effectively creates dose variability, which can translate to unpredictable symptom spikes.
There are no injection-site effects, which some people find meaningful, particularly if they are anxious about needles or self-injecting. The cost and practicalities of the tablet are covered separately, but from a tolerability perspective, the trade-off is straightforwardly GI-focused rather than local-skin-focused.
Rybelsus, the other oral semaglutide product, is licensed for type 2 diabetes rather than weight management and carries different dose strengths, if you're looking at the tablet for weight loss, Wegovy tablets (25mg maintenance) are the relevant licensed product. If you want to understand what semaglutide tablets side effects look like across the full dose range, that page covers the distinction in more depth.
There is genuine evidence that how you take the tablet, and what you eat while on it, influences tolerability. Small, low-fat meals are less likely to trigger nausea than large or greasy ones, not because the medicine requires a special diet, but because gastric emptying is already slowed, and overloading the system amplifies the effect. Eating slowly and stopping before you feel full helps most people far more than they expect.
Dose escalation exists for exactly this reason. The starting dose of 1.5mg is deliberately gentle on the system; the schedule climbs only when you're ready. Pressuring a faster step-up because progress feels slow is counterproductive, it usually increases side effects without proportionally improving outcomes. If you are currently on the intermediate dose and want to understand what that step typically involves, our page on semaglutide 7mg tablets side effects walks through what to expect at that stage. If you are moving toward the higher end of the range and want to know what to anticipate, our dedicated page on semaglutide 14mg tablets side effects covers what most people notice as they approach and settle at that dose. Your prescriber manages this, not you alone.
If side effects are persistent, affecting your sleep or making it impossible to eat adequately, that is a clinical conversation to have, not something to tolerate silently. Adjustments are possible. Our aftercare team is available seven days a week for exactly this kind of question, you don't have to wait for a scheduled review to raise a concern.
If you want to explore whether the Wegovy tablet is the right option for you, our prescribers discuss suitability and side effects as part of the free consultation. Check your eligibility and let a real clinician help you work through the picture.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.